Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-073743
Filing Date
2025-08-08
Accepted
2025-08-08 17:00:44
Documents
54
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0249439-10q_actinium.htm   iXBRL 10-Q 853514
2 CERTIFICATION ea024943901ex31-1_actinium.htm EX-31.1 9663
3 CERTIFICATION ea024943901ex31-2_actinium.htm EX-31.2 9892
4 CERTIFICATION ea024943901ex32-1_actinium.htm EX-32.1 3911
5 CERTIFICATION ea024943901ex32-2_actinium.htm EX-32.2 4118
6 GRAPHIC image_001.jpg GRAPHIC 32126
7 GRAPHIC image_002.jpg GRAPHIC 33262
8 GRAPHIC image_003.jpg GRAPHIC 39992
9 GRAPHIC image_004.jpg GRAPHIC 37108
10 GRAPHIC image_005.jpg GRAPHIC 29850
11 GRAPHIC image_006.jpg GRAPHIC 16871
12 GRAPHIC image_007.jpg GRAPHIC 45384
13 GRAPHIC image_008.jpg GRAPHIC 41824
  Complete submission text file 0001213900-25-073743.txt   4387440

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE atnm-20250630.xsd EX-101.SCH 24913
15 XBRL CALCULATION FILE atnm-20250630_cal.xml EX-101.CAL 25097
16 XBRL DEFINITION FILE atnm-20250630_def.xml EX-101.DEF 133224
17 XBRL LABEL FILE atnm-20250630_lab.xml EX-101.LAB 295938
18 XBRL PRESENTATION FILE atnm-20250630_pre.xml EX-101.PRE 150580
56 EXTRACTED XBRL INSTANCE DOCUMENT ea0249439-10q_actinium_htm.xml XML 296718
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 251199288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)